Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
Cleveland Clinic Lerner, Cleveland, OH, United States
Search grants from Cleveland Clinic Lerner
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Initiation and Regulation of Antiviral Innate Immunity
State and Community Based Childhood Lead Poisoning Prev &Surveil of Blood Lead
Grants for Graduate Programs in Health Administration
Cloning Human Lysyl Oxidase
Workshop: Networking Across the Profession to Better Use Cyberspace Tools For Discovery-Based Learning (Seatlle, WA, June 14, 2008)
Recently added grants:
MMP13 expression and function in allergic inflammation
Linguistic Experience and Generalization: Early Links between Sounds,Words, and Grammar
Cross-links at abasic sites in duplex DNA
Atlanta Pediatric Scholars Program
The Evolution of PGD addiction in Human Pancreatic Cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA095000-004
Application #
6828928
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Related projects
NIH 2003
N01 CA
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
/ Cleveland Clinic Lerner
NIH 2002
N01 CA
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
/ Cleveland Clinic Lerner
Comments
Be the first to comment on this grant